Retatrutide, also known as LY3437943, is an innovative weight loss medication developed by Eli Lilly and Company. While its full safety profile is still being established in Phase 3 trials, initial data from Phase 2 trials suggest that retatrutide is generally well-tolerated. Side effects are similar to those seen with other GLP-1 receptor agonists and tend to decrease over time.
📝 What is retatrutide?
Retatrutide is an injection that is administered once-weekly for the treatment of obesity and belongs in the same drug class as semaglutide (brand names Ozempic and Wegovy) and tirzepatide (brand names Mounjaro and Zepbound).
📝 How does retatrutide work?
Retatrutide is a unique triple agonist (tri-agonist) working on three key hormone receptors:
- Glucagon-like peptide-1( GLP-1)
- GIP (glucose-dependent insulinotropic polypeptide)
- Glucagon
This triple mechanism has a significant impact on weight loss and blood sugar levels. Like other GLP-1 receptor agonists, retatrutide regulates insulin production and slows gastric emptying, which promotes satiety and reduces appetite. Activating the GIP and glucagon receptors also increases fat breakdown and energy expenditure. Retatrutide is administered as an injection once a week.
📝 Retatrutide FDA approval status
As of now, retatrutide is not FDA approved as a weight loss drug. The drug is currently in Phase 3 clinical trials, which is typically the final stage before seeking FDA approval.
📊 Clinical trial results
Weight loss results
Data from a phase 2 clinical trial, as published in The New England Journal of Medicine involving 338 adults who had obesity or were overweight with a a Body Mass Index (BMI) of ≥27 kg/m 2, showed weight management results.
At the 24-week mark, patients receiving the drug experienced average weight loss reduction ranging from 7.2% in the 1 mg group to 17.5% in the 12 mg group, compared to 1.6% in the placebo group.
The weight-loss results continued to the 48-week endpoint, with the 12 mg (highest dose) retatrutide group achieving an average body weight reduction of 24.2%, while the placebo group only saw a 2.1% change.
Also a substantial proportion of retatrutide patients (64-100%) were able to achieve a weight loss of 5% or more, a clinically significant threshold compared to just 27% in the placebo group. In addition to its impressive treatment of obesity, retatrutide has also demonstrated:
Improvements in blood glucose control
The clinical trials have shown that retatrutide treatment can lead to significant improvements in glycemic control, as evidenced by reductions in HbA1c levels. In the phase 2 trial, 72% of participants with prediabetes at baseline were able to achieve normal HbA1c levels after 48 weeks of retatrutide therapy, compared to just 22% in the placebo group.
These findings suggest that retatrutide’s actions on the GIP, GLP-1, and GCG receptors may have a positive impact on insulin sensitivity and glucose control, potentially reducing the risk of developing obesity-related conditions like type 2 diabetes.
Improvements in cardiovascular risk factors
The clinical trials have also reported favourable changes in various cardiovascular risk factors among retatrutide recipients. Participants experienced significant reductions in blood pressure, lipid profiles (except HDL cholesterol), and waist circumference, all of which are important markers of cardiometabolic health.
❗ Potential side effects
Like any treatment, retatrutide can cause side effects, especially when adjusting dosages. Common side effects include nausea, dizziness, or diarrhoea, but these gastrointestinal (GI) side effects usually go away as your body gets used to the treatment. The safety and tolerability profile of retatrutide was generally consistent with other incretin-based therapies such as semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro).
While retatrutide has generally been well-tolerated, clinical trials have also revealed a dose-dependent pattern with GI side effects. The dose of retatrutide will determine the severity of the side effects. Participants receiving higher doses of the drug were more likely to experience mild-moderate GI issues, such as nausea, vomiting, diarrhoea, and constipation.
Overall, clinical trials showed starting with a lower dose of around 2 mg can reduce the intensity and frequency of GI side effects, compared to a higher initial dose (4 mg). This suggests that healthcare providers can use a dose-titration method to achieve the balance between weight-loss efficacy and tolerability for individual patients.
While the FDA has not yet approved retatrutide, we recommend consulting with a healthcare provider.
📝 Conclusion
For healthcare professionals, the availability of retatrutide could expand their prescribing options and from the patient’s perspective, the prospect of retatrutide’s approval is particularly exciting as it is another treatment option to help achieve their weight management goals.
Phase 3 trials of retatrutide named the Triumph trials will provide invaluable insights into the long term weight-loss results of retatrutide as well as its potential impact on obesity-related conditions, such as osteoarthritis and obstructive sleep apnea. Additionally, these trials will help establish the long-term safety profile of the drug and address concerns about potential adverse events.
Sources
- Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial – New England Journal of Medicine
- American Diabetes Association Highlights Novel Agent Retatrutide which Results in Substantial Weight Reduction in People with Obesity or Type 2 Diabetes During Late Breaking Symposium | American Diabetes Association
- Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial – PMC
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Related Articles
Can I Trust NowPatient
Certified to International Healthcare, Medical Device and Data Security Standards
Medicines Experts
Meet Our Medical Team
We are a broad skilled and passionate group of clinicians with experience of operating in health systems in the United Kingdom & United States. Providing excellent care and advice is at the heart of everything we do. You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process
WHY WE BUILT NOWPATIENT
We Are Committed to Helping Everyone, Everywhere Live Healthier Lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Your Questions Answered
For Your Peace of Mind, We Can Answer Your Questions Quickly
What does NowPatient do?
NowPatient is a digital health-technology platform functioning as both an online pharmacy and telehealth service. Packaged as a Class I software medical device, it’s accessible via web browser or mobile app (iOS and Android), and offers users worldwide on-demand access to virtual consultations, prescription services, and AI-powered health tools.
What It Does
-
- NHS Online Pharmacy: Order NHS-approved prescriptions (UK)
- Drug Savings: Access major US drug-savings programs (coupons, savings cards, manufacturer assistance, Canadian drug savings).
- Virtual Consultations: Get treated for a wide range of medical conditions by expert clinicians using a secure telehealth link.
- Medication Management: Set up refill & dose reminders, view private treatment plans, and track chronic conditions like diabetes or hypertension.
- Health-Monitoring Tools: Use AI-driven assessments for genetic risk tests, home test kits and blood-pressure monitoring.
- Wellness Insights: Access real-time pollen counts, air-quality data, BMI and type 2 diabetes risk scores, plus comprehensive health-condition information.
Get started today and benefit from Medication Reminders, Get Treated Privately, NHS Online Pharmacy, GP Appointment Booking, Rx Savings Card, Drug Coupons, US Drug Savings Programs, Health Conditions Information, Genetic Testing, Home Test Kits, BMI Risks, Type 2 Diabetes Risks, Pollen Meter, Air Quality Monitor, and lots more!
Our service is operated by experienced medical professionals in the United States and the United Kingdom.
Where is NowPatient located?
NowPatient has offices in the United Kingdom and United States.
In the UK, we are located at:
NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA
In the US, we are located at:
NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX
How can I contact NowPatient?
To contact NowPatient, please use the contact form available on the Contact Us page.
Alternatively, if you need to speak to us, you can reach us on the following numbers:
UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977
Who owns NowPatient?
NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.
Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).
Can you tell me more about your NHS online pharmacy?
NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.
Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).
Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.
How do I make a complaint?
From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.
Can you tell me more about NowPatient’s prescribing services for treatments offered?
Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:
• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old
NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla. Dr Ihtesham Sabri is the Medical Director for NowPatient and is responsible for NowPatient’s prescribing formulary and treatment guidelines, which are used by clinicians for safe and effective prescribing.
Can you tell me more about NowPatient’s US services?
Our head of US services is Dr. Jamie Winn.
You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.
What are the steps to booking a live video consultation?
Follow the steps below to book a consultation:
1Book Consultation
2Choose Consultation DateNext, you’ll be taken to the ‘Consultation Date’ screen, where you can select your preferred consultation date. You can also add any notes that might assist the clinician during your session. Click ‘Continue’ to proceed.
3Choose Consultation TimeYou will now see the ‘Consultation Time’ screen. Select your preferred time for the consultation and then click ‘Continue’.
4Choose ClinicianOn the ‘Choose Clinician’ screen, you’ll be able to view available clinicians and select the one you prefer. You can filter the list by gender and spoken languages. Once you’ve made your selection, click ‘Continue’.
5Booking ConfirmationYou will now arrive at the ‘Booking Confirmation’ screen, where you can review a summary of your booking. This screen also includes an advisory titled ‘Pre-consultation Requirements’, which offers helpful tips on how to prepare for your live video consultation. Click ‘Continue’ to proceed.
6Safety Information & RemindersYou’ll be asked to provide safety information, including: - The address where you will be during the consultation - Emergency contact details You can also opt to receive an SMS reminder 30 minutes before your scheduled video consultation.
7Final ConfirmationClick ‘Confirm Booking’ to complete the process. A pop-up will appear to confirm your booking, and you will be redirected to your account homepage. You’ll also receive confirmation via In-App and Push notifications.
If I place an order, how do I check out?
Follow the steps below to checkout:
1Go to Cart using Account Navigation
2If there is an NHS service item in the Cart - An NHS Exemption Declaration will Pop Up
3Complete the NHS Exemption Declaration for each NHS service item
4Select ‘Checkout’
5Select Delivery Address
6Select Delivery Method
7Confirm Billing Address
8Review Order
9Submit Payment
10Order Completed
11Return to Account Homepage
Is NowPatient legit and can I trust information from NowPatient?
Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.
NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.
Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:
Does NowPatient have insurance in place for the services it provides?
Yes. NowPatient is fully insured to provide pharmacy & prescribing services. Insurance not only provides peace of mind but also provides an effective safety net for both you and our clinicians.
Why is it important to choose an online pharmacy and telehealth service that is insured?
Insurance is more than just a financial safeguard, it is a signal of legitimacy and accountability.
We insure our services, so that it:
- Shows you that we are compliant with all laws and industry standards in the markets that we operate.
- Shows you that we are committed to standards of professionalism.
- Reinforces your confidence that you are dealing with a reputable provider.
Who insures your services and which services are insured?
We are insured by the National Pharmacy Association in the UK.
The scope of the services covered include:
- dispensing of prescriptions
- telehealth prescribing services.
In addition, all of the clinicians that operate on our platform have their personal indemnity insurance & scope of clinical practice validated and checked before they are able to provide services.
What are NowPatient’s opening hours?
Our office hours are:
UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST
Please note that we are closed at weekends.
In the event of a medical life-threatening emergency please call:
UK – 999
US – 911
In the event of a medical emergency which is not life-threatening please call:
UK – 111